Arthritis Clinical Trial
— FYSIOPRIMOfficial title:
Clinical Course and Prognostic Factors of Patients Receiving Physiotherapy Services in Primary Health Care in Norway (FYSIOPRIM)
NCT number | NCT03626389 |
Other study ID # | FYSIOPRIM |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 1, 2016 |
Est. completion date | June 30, 2021 |
Verified date | October 2021 |
Source | University of Oslo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background: Physiotherapists (PTs) in primary health care manage patients with a large variation in medical diagnosis, age, functional status, disability and prognosis. Lack of knowledge and systematically collected data about patients treated by PTs in primary health care has prompted this longitudinal observational physiotherapy project in Norway. This paper aims to describe a method for developing a database of patients managed by PTs in primary health care to study patients' characteristics, treatment courses and prognostic factors. The study is a longitudinal observational project, following patients through physiotherapy treatment periods in primary health care in Norway and until one year after inclusion. The project involves both private practice and municipally employed PTs working in primary health care in eight municipalities in Norway. The participants are recruited to three different parts of the project depending on age and whether they are referred to a private practice or a municipally employed PT. All data are recorded electronically, transferred and stored securely. All patients complete extensive questionnaires providing information about demographics, disability and function, pain related variables, treatment and evaluation of treatment as well as clinical tests. The PTs have access to their own patients' data. The investigators have also prepared for linkage to national patient registers and population-based studies to be able to gather further important data. This project will have important implications for physiotherapy services in primary health care. The database already contains almost 3000 patients, and data collection is ongoing. Preliminary analyses suggest that the patients included so far are representative of the larger population of patients treated by private practice or municipally employed PTs in Norway. This large scale prospective physiotherapy project will provide knowledge about the patient groups treated, treatment given as well as short and long term outcome of the patients.
Status | Completed |
Enrollment | 4985 |
Est. completion date | June 30, 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 125 Years |
Eligibility | Inclusion Criteria: - any patient seeking or receiving physiotherapy services in primary health care Exclusion Criteria: - Not understanding Norwegian or English language |
Country | Name | City | State |
---|---|---|---|
Norway | Approx 100 physiotherapists in Norway | Oslo | |
Norway | Physiotherapists in Trondheim | Trondheim |
Lead Sponsor | Collaborator |
---|---|
University of Oslo | Norwegian Fund for Postgraduate Training in Physiotherapy, Norwegian University of Science and Technology, Trondheim Kommune |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Health-Related Quality of LIfe - assessed by EuroQual 5 Dimensions questionnaire (EQ-5D) | Utility measure of Health related quality of life. Range -0.59 (worst) to 1 (best) | Baseline, 3, 6 and 12 months | |
Primary | Change in Patient-Specific Functional Scale (PSFS) | Participants identify activities that are difficult to perform and scores them from 0 (cannot perform) to 10 (perform without problems) | Baseline, 1, 3, 6 and 12 months | |
Primary | General Perceived Effect | A global assessment of change- 7 level scale. Score range 1 (very much better) to 5 (very much worse) | 3, 6 and 12 months | |
Primary | Change in Pain intensity | Pain intensity assessed by a numeric rating scale. Range 0 (no pain) to 10 (worst imaginable) | Baseline, 1, 3, 6 and 12 months | |
Secondary | Change in Work participation | Sick leave (% of full time) | Baseline, 3, 6 and 12 months | |
Secondary | Change in work ability | One questeion. Range 0 (cannot work at all) -10 (can work at my very best) | Baseline, 3, 6 and 12 months | |
Secondary | Change in pain distribution | Participants marks pain distribution in a drawing- max no of sites:112 | Baseline, 3, 6 and 12 months | |
Secondary | Change in use of analgesics containing paracetamol | Participants indicate if used last week and how often (less than daily, 1-4 per day, >5 per day) | Baseline, 3, 6 and 12 months | |
Secondary | Change in use of analgesics containing ibuprofen | Participants indicate if used last week and how often (less than daily, 1-4 per day, >5 per day) | Baseline, 3, 6 and 12 months | |
Secondary | Change in use of analgesics containing acetylsalicylacid | Participants indicate if used last week and how often (less than daily, 1-4 per day, >5 per day) | Baseline, 3, 6 and 12 months | |
Secondary | Change in emotional distress assessed by Hopkins Symptoms Check List (HSCL) | 10 questions. Score range: 1 (best) to 4 (worst) | Baseline, 3, 6 and 12 months | |
Secondary | Change in Pain Self-efficacy | Pain Self-efficacy Questionnaire (2 items). Score range 0 worst) to12 (best) | Baseline, 3, 6 and 12 months | |
Secondary | Change in health related quality of life assessed by 15D | Utility merasure of Health related quality of life - range 0 (worst) to 1 (best) | Baseline, 3, 6 and 12 months | |
Secondary | Change in catastrophising thoughts assessed by Pain Catastrophizing Scale | Baseline, 3, 6 and 12 months | ||
Secondary | Change in Neck disability Index (NDI) | Questionnaire - Score range 0 (best) to 100 (worst) | Baseline, 3, 6 and 12 months | |
Secondary | Change in Oswestry Disability Index (ODI) | Questionnaire - Score range 0 (best) to 100 (worst) | Baseline, 3, 6 and 12 months | |
Secondary | Change in Shoulder Pain and Disability Index (SPADI) | Questionnaire for patients with shoulder pain - Range 0 (no disability) to 100 (completely disabled) | Baseline, 3, 6 and 12 months | |
Secondary | Change in Disability of the Arm, Shoulder and Hand score (Quick-DASH) | Questionnaire for patients with shoulder or arm pain - Range 0 (no disability) to 100 (completely disabled) | Baseline, 3, 6 and 12 months | |
Secondary | Change in temporal aspects of pain | Participants responds with yes/no to questions on continual pain and variability in pain intensity | Baseline, 3, 6 and 12 months | |
Secondary | Change in hip disability - assessed by the Hip Disability and Osteoarthritis Outcome Score (HOOS) | Hip disability questionnaire for patient with hip pain - 5 domains (pain, symptoms, ADL, sports/recreation, quality of life). Score range 0 (best) -100 (worst) | Baseline, 3, 6 and 12 months | |
Secondary | Change in pelvic girdle pain and disability assessed by the Pelvic Girdle Questionnaire | Quesionnaire questionnaire for patient with pelvic girdle pain - range 0 (no disability or pain) to 100 (high disability and pain) | Baseline, 3, 6 and 12 months | |
Secondary | Change in knee disability - assessed by the Knee Disability and Osteoarthritis Outcome Score (KOOS) | Knee disability questionnaire for patient with knee pain - 5 domains (pain, symptoms, ADL, sports/recreation, quality of life). Score range 0 (best) -100 (worst) | Baseline, 3, 6 and 12 months | |
Secondary | Change in physical functioning assessed by the Physcal function domain of Short Form 36 - (SF-36) | Sumscore with range 0 (worst) to 100 (best) | Baseline, 3, 6 and 12 months | |
Secondary | Change in insomnia problems assessed by the Insomnia Severity Index | Questionnaire - score range 0 (no insomnia problems) to 28 (severe insomnia problems) | Baseline, 3, 6 and 12 months | |
Secondary | Change in 6 min walk | 6 min walk - timed measure (s) | Baseline, 3, 6 and 12 months | |
Secondary | Change in stair climb capacity | Stair climb 3 flights - up and down; timed measure (s) | Baseline, 3, 6 and 12 months | |
Secondary | Change in physical capacity assessed by 30 s sit to stand | Assessed as the number of times to complete a sit to stand and sit cycle witin 30 s | Baseline, 3, 6 and 12 months | |
Secondary | Short Physical Performance Battery | 4 tests of Physical performance | Baseline, 3, 6 and 12 months | |
Secondary | Fulfilment of expectations | One question | 3, 6 and 12 months | |
Secondary | Benefit of treatment | One question | 3, 6 and 12 months | |
Secondary | Fulfillment of treatment goals | patients evaluate if the individually defined treatment goals are met, partially met or not met at all | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04228458 -
ThermRheum Version 1
|
N/A | |
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Completed |
NCT00069342 -
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
|
||
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Recruiting |
NCT02498808 -
Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?
|
N/A | |
Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
Enrolling by invitation |
NCT02487888 -
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
|
N/A | |
Withdrawn |
NCT02136251 -
Total Shoulder Replacement Outcomes With Autologous Bone Graft as Fixator for Glenoid Anchor Peg.
|
||
Completed |
NCT02143206 -
Modifying Exercise for the COPD Patient
|
||
Completed |
NCT01407874 -
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
|
Phase 2 | |
Completed |
NCT01285843 -
Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component
|
N/A | |
Completed |
NCT01172327 -
Self-Directed Exercise Program for Adults With Arthritis
|
N/A | |
Completed |
NCT00987870 -
Safety and Efficacy of BFH772 in Psoriasis Patients
|
Phase 1/Phase 2 | |
Completed |
NCT01184924 -
Evaluation of the Arthritis Foundation Tai Chi Program
|
N/A | |
Completed |
NCT00750984 -
A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing
|
N/A | |
Active, not recruiting |
NCT00611585 -
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
|
N/A | |
Completed |
NCT00379184 -
Sensitization in Osteoarthritic Knees
|
N/A | |
Completed |
NCT00403676 -
Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease
|
N/A | |
Completed |
NCT00175448 -
Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement Surgery
|
N/A |